Cargando…
Intrathecal baclofen in paroxysmal sympathetic hyperactivity: Impact on oral treatment
INTRODUCTION: Intrathecal baclofen (ITB) is a commonly used treatment in severe spasticity. The main objective of this study was to assess the impact of ITB on reduction or withdrawal of oral drugs in patients with paroxysmal sympathetic hyperactivity (PSH) after severe traumatic brain injury. METHO...
Autores principales: | Pucks‐Faes, Elke, Hitzenberger, Gabriel, Matzak, Heinrich, Verrienti, Giulio, Schauer, Robert, Saltuari, Leopold |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6236240/ https://www.ncbi.nlm.nih.gov/pubmed/30264872 http://dx.doi.org/10.1002/brb3.1124 |
Ejemplares similares
-
Eleven years’ experience with Intrathecal Baclofen – Complications, risk factors
por: Pucks‐Faes, Elke, et al.
Publicado: (2018) -
Intrathecal Baclofen in Hereditary Spastic Paraparesis
por: Pucks-Faes, Elke, et al.
Publicado: (2019) -
Complications After Dual Placement of a Baclofen Pump and Ventricular Shunt in Individuals With Severe Brain Injury
por: Pucks-Faes, Elke, et al.
Publicado: (2020) -
On the recovery of disorders of consciousness under intrathecal baclofen administration for severe spasticity—An observational study
por: Halbmayer, Lucas‐Michael, et al.
Publicado: (2022) -
EUROPEAN EXPERT CONSENSUS ON IMPROVING PATIENT SELECTION FOR THE MANAGEMENT OF DISABLING SPASTICITY WITH INTRATHECAL BACLOFEN AND/OR BOTULINUM TOXIN TYPE A
por: BIERING-SØRENSEN, Bo, et al.
Publicado: (2021)